Comparison of Biopsy and Diagnosis Code Based Breast Cancer Phenotypes – OHDSI

$ 18.50

4.6
(682)
In stock
Description

New Advances in Molecular Breast Cancer Pathology - ScienceDirect

AI-enabled routine H&E image based prognostic marker for early-stage luminal breast cancer

Applied Sciences, Free Full-Text

Predicting breast cancer biopsy outcomes from BI-RADS findings using random forests with chi-square and MI features

PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation - ScienceDirect

Cancers, Free Full-Text

DBMI Trainees, Faculty Highlight Path, Benefits To Global Research During 2022 OHDSI Symposium - Columbia DBMI

Applied Sciences, Free Full-Text

PDF) Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes

HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model - ScienceDirect

Sensitivity, specificity, and accuracy of a liquid biopsy approach utilizing molecular amplification pools